The capacity of mouse spleen conventional dendritic cells (cDC) and plasmacytoid dendritic cells (pDC) to produce interferon (IFN)-γ or IFN-α was assessed, and compared to that of natural killer (NK) cells and the recently identified interferon-producing killer dendritic cells (IKDC), both of which are frequent contaminants in DC preparations. Fully developed cDC or pDC, if free of NK cells or IKDC, showed little capacity for IFN-γ production. However an early developmental form of the CD4 -8 + cDC subtype, and the Ly6C -Ly49Q -pDC subtype, both were able to produce moderate amounts of IFN-γ, although less than IKDC. In response to toll-like receptor 9 stimuli both the Ly6C + Ly49Q + and the Ly6C -Ly49Q -pDC subtypes were effective producers of IFN-α.
Abstract
The capacity of mouse spleen conventional dendritic cells (cDC) and plasmacytoid dendritic cells (pDC) to produce interferon (IFN)-γ or IFN-α was assessed, and compared to that of natural killer (NK) cells and the recently identified interferon-producing killer dendritic cells (IKDC), both of which are frequent contaminants in DC preparations. Fully developed cDC or pDC, if free of NK cells or IKDC, showed little capacity for IFN-γ production. However an early developmental form of the CD4 -8 + cDC subtype, and the Ly6C -Ly49Q -pDC subtype, both were able to produce moderate amounts of IFN-γ, although less than IKDC. In response to toll-like receptor 9 stimuli both the Ly6C + Ly49Q + and the Ly6C -Ly49Q -pDC subtypes were effective producers of IFN-α.
However IKDC, which efficiently produced IFN-γ and showed immediate cytotoxicity on NK target cells, did not produce IFN-α under these conditions.
Introduction
Interferons are key effector cytokines of the innate and adaptive immune systems. Type 1 interferons, such as IFN-α, are produced in large quantities by activated plasmacytoid dendritic cells (pDC), and are particularly important in resistance to virus infections [1] [2] [3] [4] [5] . The inflammatory cytokine IFN-γ is produced in large quantities by Th1 effector CD4 T cells, by CD8 T cells and by natural killer (NK) cells [6] [7] [8] . Interferons also play crucial roles in the initiation of adaptive immune responses. Type 1 interferons help activate the conventional dendritic cells (cDC) which are needed to initiate primary T cell responses. IFN-γ itself is needed to initiate the differentiation of activated T cells towards the IFN-γ producing Th1 state. Thus, the production of even relatively small amounts of interferons by even minor cell populations could be important in the early steps of immune responses.
It has been reported by several laboratories, including our own [9] [10] [11] [12] , that DC are able to produce IFN-γ when stimulated with IL-12 and IL-18. Despite this common finding, there was a discrepancy in the cDC subtype considered responsible, it being attributed mainly to CD4 -8 + cDC by the Japanese group 10 , mainly to CD4 -8 -cDC by our group 9 and to both of these subsets by others 11 .
However, such IFN-γ production by DC preparations has since been widely attributed to NK cells, since only a trace contamination could account for the modest level of IFN-γ production found.
A further complication to the assessment of IFN production by DC subtypes is the recent recognition of a type of cell with properties overlapping those of DC and NK cells. The existence of DC with NK-like killing properties had been recognised previously in rodents [13] [14] [15] [16] . Human NK clones have been shown to be effective at antigen presentation 17 , and human pDC malignancies display NK cell markers [18] [19] [20] [21] . Recent studies by two groups have provided sufficient information to consider these as a distinct cell type in mice, now termed Interferon Producing Killer Dendritic Cells (IKDC) [22] [23] [24] . Since these IKDC are potent producers of IFN-γ, and since they express surface
For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From CD11c as do DC, it seemed possible these were the source of the IFN-γ production in DC preparations. IKDC have also been reported to produce IFN-α 22, 23 . Since IKDC express some surface markers characteristic of pDC and are likely to be found in pDC preparations, a further question was whether any portion of the IFN-α production by pDC preparations could be attributed to IKDC. A capacity to produce substantial amounts of both IFN-γ and IFN-α would make IKDC a uniquely potent cell type.
To clarify these issues we isolated spleen cDC and pDC subtypes in such a way as to segregate them from NK cells and IKDC, then we tested them for IFN-α and IFN-γ production. We found very little IFN-γ production by fully developed cDC or pDC once free of NK-like cell contaminants, but a CD8 -precursor of the CD8 + cDC subset and a Ly6C -form of pDC, both routinely found in DC preparations, were able to produce moderate levels of IFN-γ. Although we obtained extensive IFN-γ production by cells resembling IKDC, we found no IFN-α production by these cells in response to a toll-like receptor (TLR-) 9 stimulus. In our hands such IFN-α production was restricted to pDC lacking NK cell markers and lacking NK-like killing activity. The IFN-α producers included pDC that were Ly6C -as well as Ly6C + .
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Materials and methods

Mice
Mice were produced at The Walter and Eliza Hall Institute (WEHI) animal facility under specific pathogen free conditions. Female 5-7 week old C57Bl/6J Wehi mice were used in most experiments.
cDC isolation and enrichment
The standard procedure for isolation and enrichment of conventional DC (cDC) was based on our earlier procedures 25, 26 and is summarised in Fig. 1 . All media were at pH 7.2 and iso-osmotic with mouse serum (308mOs). Spleens (8) were cut into small fragments and digested, with frequent mixing, for 20 minutes at room temperature (22 o C) in 7ml modified RPMI-1640 medium-2% foetal bovine serum (FCS) containing collagenase (1mg/ml; Worthington Biochemical, Freehold, NJ;
verified free of trypsin-like protease activity) and DNAase I (0.02mg/ml; Boehringer Mannheim, Mannheim, Germany). EDTA solution (600µl, 0.1M, pH 7.2) was then added and mixing continued for 5 min. Undigested material was removed by filtration through a coarse sieve. All subsequent steps were at 0-4 o C, using a divalent metal free buffered balanced salt solution containing EDTA (EDTA-BSS). Cells from the digest were centrifuged to a pellet and the pellet resuspended in 10ml of a 1.077g/cm 3 medium, made by dissolving Nycodenz powder (Nycomed, Oslo, Norway) in water as a dense stock (0.37M) then diluting in EDTA-BSS to give the required density at 308mOs.
Further Nycodenz was layered below the Nycodenz cell suspension, EDTA-FCS layered above, then the tube centrifuged at 1700g for 10 min. The light density fraction (<1.077g/cm 3 ) was collected, diluted in EDTA-BSS, recovered by centrifugation, then incubated for 30 min with the following mAb: anti-CD3 (KT3-1.1); anti-Thy1 (T24/31.7); anti-B220 (RA3-6B2) anti-Gr1 (RB68C5); anti-erythrocyte (TER-119). All mAb were titrated and used at near saturation conditions except anti-Thy1, which was used at 25% saturation. The cells were washed free of excess mAb, then antibody coated cells removed using anti-rat Ig coupled Biomag beads (Qiagen,
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Clifton Hill, Australia). The beads and cells at a 10:1 ratio were mixed as a concentrated slurry by slow rotation for 20min, diluted with EDTA-BSS, then the beads and bound cells removed with a magnet, using two removal steps. In the modified procedure to remove cells bearing NK markers, an additional depletion step was used prior to staining and sorting (Fig. 1) . The cells recovered after the anti-rat Ig depletion step were incubated with saturation levels of biotinylated mAb against CD49b (DX5) and against CD161c (NK1.1; clone PK136), washed then incubated (in BSS containing 0.5% FCS) with anti-biotin MACS magnetic particles (Miltenyi Biotec, Germany) following the manufacturers instructions, then passed over a Miltenyi column (Miltenyi Biotec, Germany), collecting the unbound cells. The enriched spleen cDC obtained by both protocols were around 80% pure.
Staining, sorting and analysis of cDC subsets
To effect the final purification of cDC and segregate them into subtypes, the enriched cDC preparation was normally stained with mAb against CD11c (N418-FITC), CD4 (GK1.5-Alexa 594) and CD8α (YTS 169.4-APC) and with CD49b (DX5-biotin with PE-streptavidin second stage) for analysis. Propidium iodide (1µg/ml) was included in the final wash to label dead cells. When the
CD4
-8 -cDC subset was isolated for further subdivision, the anti-CD11c was conjugated to APC, the anti-CD4 and anti-CD8 mAb were both conjugated to Alexa 594, and the cells were also stained with mAb against CD172a (Sirp-α) (P84-FITC). For further analysis the cells were also stained for 
pDC isolation and enrichment
The procedure was based on our previous study 27 , and is summarised in Fig. 2a . The production of a spleen cell suspension and isolation of the light density fraction was identical with the procedure 
pDC purification and analysis
To effect final purification and analysis of pDC subsets (Fig. 2a) , the pDC enriched preparation was normally stained for CD11c (N418-Alexa 594), CD45RA (14.8-APC), Ly6C (5075-3.6-FITC) and
CD49b (DX5-biotin with PE-streptavidin second stage). When the cells were stained for Ly49Q
(2E6-FITC), the mAb against Ly6C was a biotin conjugate with PE-streptavidin second stage and CD49b staining was omitted. Dead cells were stained with propidium iodide as for cDC. The sorting and analysis was as specified for cDC.
NK cell isolation
Splenic cell suspensions were generated using collagenase digestion as in the DC isolation procedure. Red cells and dead cells were removed using a 1.091g/cm 3 The optical density of each sample was read at 405-490nm using an ELISA plate reader.
Cytotoxicity assays
The YAC-1 target cells were harvested in exponential growth phase, washed and labelled by incubating 10 6 cells with 100µl ( 51 Cr) sodium chromate in 100ml medium for 1.5hr at 37 o C then washed four times. Target cells (10 4 ) and various levels of effector cells were plated in 0.2ml modified RPMI-1640 10% FCS medium in 96-well round-bottom plates, centrifuged for 1 min at 335g then incubated 4hr at 37 o C. After centrifugation (5 min, 400g) 100µl of supernatant was removed and the chromium release (E) measured by γ-emission counting. Spontaneous chromium release (S) was determined by incubating target cells alone. Maximum release (M) was determined after target cell lysis with 10% triton-X. Specific lysis was calculated according to the formula:
% lysis = 100 x (E-S)/(M-S). Spontaneous release was always below 10%.
Antigen cross-presentation assays
For the in vitro presentation assay the cDC subsets were freshly isolated from unstimulated mice.
For the in vivo presentation assay, as described previously 28 , mice were injected with 30µg
lipopolysaccharide (Sigma-Aldrich), then 1hr later with 3mg ovalbumin (Sigma-Aldrich), then the cDC subsets isolated 19hr later. Cross-presentation was assessed by the ability to stimulate ovalbumin-specific TCR-transgenic naïve CD8 + OT-I T cells, isolated as described previously ovalbumin was added to the cultures at 250µg/ml. After 2 days culture, the wells were pulsed with 1µCi/well of ( 3 H) thymidine for 8hr, the cells harvested onto glass fibre filters and the incorporation into cellular DNA determined by liquid scintillation counting.
Results
Spleen cDC preparations, cDC subsets and IKDC contaminants
Our standard protocol for isolation of cDC is given in Fig. 1 hi . This provides another approach to segregating these cDC subtypes.
This standard protocol produced cDC subtypes which were around 99% pure on reanalysis, but we could not eliminate the possibility of contamination below the 1% level. It became clear that our enriched cDC preparations, prior to sorting, contained around 0.5% of cells which were light in density, expressed moderate levels of CD11c, and which also expressed the NK marker CD49b, revealed by the mAb DX5 (Fig. 3a) . These resemble IKDC, the recently described "hybrid" NK-DC cells 22, 23 . Most but not all of these IKDC were eliminated by our gating for CD11c hi cDC (Fig. 3a) .
As an approach to eliminating all IKDC, as well as any residual conventional NK cells, we introduced an additional MACS depletion step using antibodies selective for NK cells ( 
IFN-γ production by cDC subtypes and by IKDC
We examined the possibility that the IFN-γ production by our cDC preparations, and in particular by the CD4 -8 -cDC subset 9 , was due to trace contamination by NK cells or by IKDC. Indeed, the CD49b + cells present in our standard cDC enriched preparations produced almost as much IFN-γ in response to IL-12 and IL-18 as isolated NK cells (confirming their likely identification as IKDC) and this was 50-100 times higher on a per cell basis than our most active cDC subset (Fig. 3b) . We initially tried intracellular staining and flow cytometric analysis to determine if the IFN-γ production by our standard cDC preparations was due to a few contaminating cells making a lot of IFN-γ, or to many cDC each making a little. However the high noise of the assay rendered attempts to count a few high producers inconclusive, and the IFN-γ production on a per cell basis was too low to detect a significant shift above the background staining if most cells were IFN-γ producers.
Accordingly, in subsequent studies we used an ELISA assay to determine IFN-γ levels in the supernatant of cDC cultures, since this was a low background, low noise assay allowing measurements over a wide range of IFN-γ secretion.
Using the ELISA assay, we confirmed the production of IFN-γ by the CD4 -8 -cDC subset isolated by our standard procedure, although the level was low compared to NK cells (Table 1 To determine in a direct way the possible contribution of IKDC to the IFN-γ production by our isolated cDC subpopulations, we carefully analysed the level of cells bearing CD49b in the various fractions, comparing the standard cDC subset preparations with those from cDC pre-depleted of cells bearing NK markers (Fig. 3a) . Although our standard enriched cDC contained around 0.5% putative IKDC, most but not all of these were depleted by the CD11c hi gate we routinely used to select cDC. Pre-depletion of cells bearing NK markers reduced this initial level of putative IKDC in the cDC preparation around 250-fold (Fig. 3a) . This pre-depletion of cells bearing NK markers did result in some reduction (around 2-fold) in the final IFN-γ production by the cDC subsets,
suggesting that traces of contaminating IKDC had made some contribution to the measured IFN-γ production by the original cDC subset preparations (Fig. 3b) . However, significant IFN-γ production was still obtained when IKDC or NK cells were below detectable levels. Importantly, the CD4 -8 -cDC subset was still a significant producer of IFN-γ when not even a single CD49b bearing cell could be detected on analysis of 10 5 cells (Figs. 3a, 3b ). Thus even though NK cells and IKDC were around 100-fold more efficient as IFN-γ producers, they could not explain this level of IFN-γ production. These results support our previous conclusion 9 , and the conclusion from Table 1 , that the major source of IFN-γ by spleen cDC preparations is the CD4 -8 -cDC fraction.
Developing cDC within the CD4 -8 -cDC preparation
We have recently demonstrated that spleen contains a substantial pool of immediate precursors of cDC 30 . Most of these are of medium rather than low buoyant density, lack surface expression of MHC II and express only moderate levels of CD11c. However, some of these cDC precursors appear to be in transit towards the fully developed steady-state spleen cDC, having already acquired the light density and higher surface CD11c characteristics, and having already begun surface MHC (Fig. 5a ). In addition, the minor CD172a -CD4 -8 -cDC subset was almost as effective as CD8 + cDC in taking up exogenous soluble antigen and presenting it on MHC I ("cross-presentation" 11,28,31 ) (Fig. 5b) . When the CD172a -CD4 -8 -cDC subset was isolated from mice that had been injected with ovalbumin and lipopolysaccharide a day previously 28 , it was as efficient as CD8 + cDC in activating the ovalbuminspecific CD8 + T cells (Fig. 5c) . In both these in vitro and in vivo tests, the major CD172a + CD4 -8 -cDC subset was poor at cross-presentation, as expected of CD8 -cDC (Fig. 5b, 5c ). In conclusion, the CD4 -8 -cDC fraction as isolated included a small proportion of early forms of the CD8 + cDC sublineage. Fig. 4b, it was clear that all of the capacity of CD4 -8 -cDC to form IFN-γ was concentrated within the minor CD172a -sub-fraction, and this fraction now showed a more impressive capacity on a cell-for-cell
basis. An important conclusion was that all the fully developed spleen cDC subtypes, now including the CD172a + CD4 -8 -cDC, showed only a very low capacity for IFN-γ production.
Lack of cytotoxic activity by the cDC precursors within the CD4-8-cDC fraction
Since the CD172a -precursors of CD4 -8 + cDC within the CD4 -8 -population produced IFN-γ, as do NK cells, we tested if they possessed an NK-like cytotoxic activity on the NK target cell YAC-1.
However, when compared to NK cells, they had no ability to kill YAC-1 cells (Fig. 6a) . In this respect they gave results identical to the major CD172a + subset of CD4 -8 -cDC, which as expected also lacked cytotoxic activity. In both cases this was in line with their lack of expression of the NK cell marker CD49b.
Spleen pDC preparations, pDC subsets and IKDC contaminants
Since IKDC appear closer to pDC than to cDC in surface phenotype 22, 23 , we examined their contribution to pDC preparations. Our protocol for the isolation of pDC is given in Fig. 2a . The approach was similar to that used for cDC, but the mAb used for immunomagentic bead depletion differed. B cells were depleted with anti-CD19, rather than with anti-CD45R (B220) which also depletes pDC. Granulocytes were depleted with a mAb specific for Ly6G that has no reactivity with Ly6C, to avoid any possible pDC depletion. Some mAb reactive with cDC were included to reduce the load of cDC, although they did not give complete removal. However, since we wished to
For personal use only. on November 16, 2017. by guest www.bloodjournal.org From examine the relationship of IKDC to the pDC subsets, no depletion of cells bearing NK markers was applied. The pDC were finally sorted and separated from residual cDC based on their high expression of CD45RA and intermediate rather than high levels of CD11c (Fig. 2a) 32, 33 . The Ly49Q -pDC have been reported to develop into Ly49Q + pDC in culture 33 . Accordingly, we stained spleen pDC preparations for both Ly6C and Ly49Q and crosscorrelated the expression of the two markers. Indeed there was an extensive correlation, the Ly6C -pDC being mainly Ly49Q -, and the Ly6C + pDC being mainly Ly49Q + (Fig. 2b) .
To determine if any IKDC were present within our spleen pDC preparations, we stained for CD49b using the mAb DX5. As shown in Fig. 2a, a IKDC, showed a wider range of CD45RA expression than pDC and some were also present in the CD45RA int fraction of the enriched pDC preparation (Fig. 2a) . Such cells would not readily be depleted using anti-CD45R mAb, so probably contributed to the few IKDC which contaminated our standard cDC preparations.
NK-like killing by IKDC
To check that the CD49b + cells isolated from our pDC preparations were equivalent to the IKDC described by others 22, 23 , we tested their cytotoxic activity on the NK target cell YAC-1. Indeed these CD49b + Ly6C -CD11c + CD45RA + putatative IKDC showed an immediate strong cytotoxic activity on YAC-1 cells in a 4hr assay (Fig. 6b) . This was similar to the activity of NK cells isolated from spleen suspensions (Fig 6a) . In contrast, the CD49b depleted pDC and cDC preparations showed no killing of YAC-1 targets (Fig. 6b) . The extent of killing was not notably increased by including CpG1668 in the cytotoxic assays to activate the IKDC (data not shown). When these putative IKDC were first pre-activated by overnight culture with CpG1668 together with GM-CSF, duplicating the approach of others 22 , the viable cells which survived were also cytotoxic to YAC-1;
however under these conditions viable cell survival was only 10 -30 % (data not shown). By the criterion of NK-like killing, the CD49b + cells in our pDC preparations could be classed as IKDC.
Production of interferons by pDC and IKDC
To determine which interferons were produced by the 'true' pDC and which were produced by the putative IKDC 'contaminants', the sorted fractions of Fig. 2a were assayed for the production in culture of IFN-α in response to the TLR-9 stimuli CpG2216 or CpG1668, and for the production of IFN-γ in response to IL-12 and IL-18.
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In contrast to the results on IFN-α production, IFN-γ was produced at high levels by the CD49b + cells within the pDC preparations (Fig. 7) , indicating that these could indeed be called IKDC.
However, no IFN-γ was produced by the typical CD45RA hi CD11c int Ly6C + spleen pDC, and only moderate amounts were produced by the presumed earlier pDC form, the Ly6C -CD49b -subset.
Thus there was little overlap in the capacity to produce these two interferons in response to the stimuli used, the pDC producing IFN-α, the IKDC producing IFN-γ.
Discussion
The main objective of this study was to determine the extent of production of interferons by fully developed, steady-state DC of the type found in mouse spleen. The existence of multiple subtypes of DC and of other cells with properties that overlap those of DC, made this a demanding exercise.
The problems are emphasised by the recent description of a cell type termed IKDC [22] [23] [24] , which like DC is light in density and expresses surface CD11c, CD45R (B220) and MHC II, but which also has the cytotoxic potential and surface markers of NK cells. The true lineage origins of these IKDC are yet to be determined. Such IKDC are likely to be a contaminant in most cDC preparations where expression of CD11c is the main selection criterion. Because many IKDC express relatively high levels of CD45R and CD45RA, they will be a component of pDC preparations selected by these criteria. Stringent exclusion of cells bearing NK markers, such as CD49b (DX5), is required to eliminate these cells.
Since IKDC are capable of producing large amounts of IFN-γ, much of the modest production obtained from conventional cDC and pDC preparations is likely to derive from a small number of IKDC contaminants. Even though most IKDC were eliminated by our previous multi-step cDC purification procedure, trace amounts may have contributed to the IFN-γ production we obtained.
However, using very stringent criteria to exclude all cells bearing NK markers, our cDC preparations still were capable of a low but significant level of IFN-γ production. We have now tracked down the minor cDC subset responsible for this IFN-γ production.
We have found that spleen contains a reservoir of precursors of cDC, but not of pDC 30 . Most of these pre-cDC lack surface MHC-II, express only intermediate levels of CD11c and moderate buoyant density, so are separable from fully developed steady-state cDC. However, because of the rapid turnover of spleen cDC 34 , spleen must contain cells in transit between pre-cDC and fully developed cDC. We have now identified such a minor population of cDC within the CD4 -8 35, 36 . We now find it is these "in transit" early forms of the CD8 + cDC lineage which produce all the IFN-γ we had attributed to the CD4 -8 -cDC population 9 . This reconciles our finding with that of others 10 who found the CD8 + cDC rather than the CD4 -8 -cDC to be the cDC subset producing IFN-γ. Depending on the rate of surface CD8α acquisition, the gatings used to select the cDC subsets and the status of the mice used, these IFN-γ producing early CD8 + cDC might fall into one or another sorting gate.
The immunological significance of the potential of splenic early CD8 + cDC to produce moderate amounts of IFN-γ is not clear. These cells do have the potential to produce the IL-12p70 needed to induce IFN-γ secretion. It is of interest that a presumed early form of pDC, the Ly6C -Ly49Q -subset, also has a similar moderate capacity to produce IFN-γ. This IFN-γ production capacity may provide an early "priming" function to allow Th1 T-cell development. Alternatively, many precursor cells may have some capacity to produce IFN-γ and the physiologically important aspect may be the switching off of this capacity once cDC and pDC are fully developed. Whatever the interpretation, it is important to note that the fully developed, steady-state cDC and pDC which interact with naïve T-cells have little capacity for IFN-γ production.
Amongst DC, the pDC are considered to be the major producers of type 1 interferons in response to viral and other infections and in response to the TLR-9 stimulus CpG [1] [2] [3] [4] [5] . We have noted that CD4 -8 + cDC preparations are capable of some IFN-α production in response to a combination of poly I:C and CpG stimulation 9 . The interpretation of this finding is now uncertain, since activated forms of pDC express CD8α and down-regulate CD45RA 27 , so traces of activated pDC may have contributed to this IFN-α production. However, it is now clear that all cDC have a capacity to produce IFN-α if appropriately stimulated, as shown by intracellular stimulation of cDC subtypes with double-stranded RNA 29 , so it is important to specify the nature of the stimulus used. We now demonstrate that the Ly6C -CD45RA hi CD11c int cells in spleen and BM pDC preparations are fully capable of IFN-α production in response to the TLR-9 stimulus CpG, so they can be classified as pDC. They correspond to the Ly49Q -pDC described by others 32, 33 and considered to be early forms of pDC. Ly49Q -pDC have already been reported to produce IFN-α in response to CpG 32, 33 .
Although Ly6C -cells in BM pDC preparations have been reported to be poor producers of IFN-α 37 , these preparations were apparently dominated by the Ly6C -CD49b + cells which we now find to be inactive. By our criteria only the CD49b -cells within pDC preparations can be classed as IFN-α producing pDC, but these will include the Ly6C -Ly49Q -and Ly6C + Ly49Q + components.
A striking finding in our study is the dichotomy between IFN-γ and IFN-α production amongst the cells we isolate from pDC preparations. The putative IKDC, CD45RA + CD11c int Ly6C -CD49b + , although being potent producers of IFN-γ, failed to produce IFN-α in response to CpG stimulation.
This finding is in line with an earlier study showing similar cells from BM were poor producers of IFN-α 37 , but contrasts with the two recent reports claiming that IKDC produce both IFN-γ and IFN-α 22, 23 . Some subtle difference in the status of the mice or in stimulation conditions could possibly explain this discrepancy, although the use of CpG as a TLR-9 stimulus was a common factor, and we tested both the 1668 and the 2216 forms of CpG. However, since the IFN-α production was lower than for pDC and was variable in the previously published report 22 , the discrepancy may have been due to the presence of a proportion of Ly6C Figure 2 : (a) The procedure for isolating pDC and IKDC. The initial steps were similar to those used for cDC (Fig. 1) For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From The cDC subsets were isolated by the standard procedure of Fig. 1 
